BiotechTube

GSK1265744 10 mg oral solution + GSK1265744 5 mg tablet + GSK1265744 5 mg tablet

Phase 1Completed
0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

HIV Infection

Conditions

HIV Infection, Infection, Human Immunodeficiency Virus

Trial Timeline

Jun 1, 2008 → Aug 1, 2008

NCT ID
NCT00812318

About GSK1265744 10 mg oral solution + GSK1265744 5 mg tablet + GSK1265744 5 mg tablet

GSK1265744 10 mg oral solution + GSK1265744 5 mg tablet + GSK1265744 5 mg tablet is a phase 1 stage product being developed by Shionogi for HIV Infection. The current trial status is completed. This product is registered under clinical trial identifier NCT00812318. Target conditions include HIV Infection, Infection, Human Immunodeficiency Virus.

What happened to similar drugs?

20 of 20 similar drugs in HIV Infection were approved

Approved (20) Terminated (3) Active (0)
✅Levofloxacin + LevofloxacinDr. Reddy's LaboratoriesApproved
✅Levofloxacin + Solifenacin succinate + Placebo (for Solifenacin succinate)Astellas PharmaApproved
✅amphotericin B liposomal (Ambisome)Astellas PharmaApproved
✅Ciclosporin and Mycophenolate-mofetil + Tacrolimus and Mycophenolate-mofetil + Tacrolimus and Mycophenolate-mofetil with change from Mycophenolate-mofetil to EverolimusAstellas PharmaApproved
✅Cefiderocol + Ampicillin-sulbactam + Colistin + MeropenemJohnson & JohnsonApproved
✅Darunavir + Etravirine + Emtricitabine/tenofovir disoproxil fumarate + Raltegravir + Second line ART regimens - based on a boosted protease inhibitor (bPI) plus two nucleoside analogues (NRTIs) + Study provided drugs according to patient resistance profile (DRV, ETR, RTV, FTC/TDF) + any in country available drug as applicable & availableAbbVieApproved
✅Lopinavir/RitonavirAbbVieApproved

Hype Score Breakdown

Clinical
6
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00812318Phase 1Completed

Competing Products

20 competing products in HIV Infection

See all competitors
ProductCompanyStageHype Score
mRNA-1647ModernaPhase 2
0
mRNA-1647ModernaPhase 2
0
mRNA-1647ModernaPhase 2
0
mRNA-1944ModernaPhase 1
0
mRNA-1189ModernaPhase 2
0
mRNA-1647ModernaPhase 1
0
mRNA-1653ModernaPhase 1
0
mRNA-1647ModernaPhase 2
0
mRNA-1653ModernaPhase 1
0
mRNA-1195.1ModernaPhase 1
0
mRNA-1647ModernaPhase 1
0
mRNA-1647ModernaPhase 3
0
DFA-02 Antibiotic Gel + DFA-02 Placebo GelDr. Reddy's LaboratoriesPhase 2
32
DFA-02 + PlaceboDr. Reddy's LaboratoriesPhase 1/2
29
Levofloxacin + LevofloxacinDr. Reddy's LaboratoriesApproved
36
BSG005Alkem LaboratoriesPhase 1/2
39
Zotatifin + PlaceboeFFECTOR TherapeuticsPhase 1
19
AAVLP-HPV + Placebo2A PharmaPhase 1
19
CT-P59CelltrionPhase 1
29
CT-P63 + PlaceboCelltrionPhase 1
29